Search

Author/Creator Taira, Naruto

11. Switch maintenance endocrine therapy plus bevacizumab after bevacizumab plus paclitaxel in advanced or metastatic oestrogen receptor-positive, HER2-negative breast cancer (BOOSTER): a randomised, open-label, phase 2 trial. Issue 5 (May 2022)

Authors:
Saji, Shigehira; Taira, Naruto; Kitada, Masahiro; Takano, Toshimi; Takada, Masahiro; Ohtake, Tohru; Toyama, Tatsuya; Kikawa, Yuichiro; Hasegawa, Yoshie; Fujisawa, Tomomi; Kashiwaba, Masahiro; Ishida, Takanori; Nakamura, Rikiya; Yamamoto, Yutaka; Toh, Uhi; Iwata, Hiroji; Masuda, Norikazu; Morita, ...
Journal:
Lancet oncology
Issue:
Volume 23:Issue 5(2022)
Page Start:
636
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

12. Systemic therapy and prognosis of older patients with stage II/III breast cancer: A large-scale analysis of the Japanese Breast Cancer Registry. (September 2021)

Authors:
Yamada, Akimitsu; Kumamaru, Hiraku; Shimizu, Chikako; Taira, Naruto; Nakayama, Kanako; Miyashita, Mika; Honma, Naoko; Miyata, Hiroaki; Endo, Itaru; Saji, Shigehira; Sawaki, Masataka
Journal:
European journal of cancer
Issue:
Volume 154(2021)
Page Start:
157
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗